Riskpilot← Back to searchSign inGet full accessMerck Life Science AB
ABActiveOrg 5561203000Frösundaviks Allé 1Wholesale of other machinery and equipment · NACE 4664Est. 196840 employees
Revenue 2024
SEK 1,2B
-7% vs 2023
EBITDA margin
50.8%
-8% vs 2023
Equity ratio
92.7%
Financial strength
Net profit 2024
SEK 504,6M
-9% vs 2023
| Revenue | SEK 1,2B | -7% |
| EBITDA | SEK 606M | -8% |
| Net profit | SEK 504,6M | -9% |
| Total assets | SEK 791,4M | -45% |
| Equity | SEK 734M | -45% |
| Employees | 40 | — |
Legal name
Merck Life Science AB
Org number
5561203000
Legal form
Aktiebolag
NACE code
4664 · Wholesale of other machinery and equipment
Founded
22 oktober 1968
Share capital
SEK 10 300 000
Employees
40 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, utveckla, tillverka, marknadsföra, köpa och sälja utrustning, förbrukningsmateriel, laboratoriekemikalier och - instrument, kromatografi och annan därmed förenlig verksamhet, värdepappersförvaltning, samt uthyrning av lokaler.
Address
Frösundaviks Allé 1
Phone
+46856244500
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 746 094 | 929 235 | 1 322 751 | 1 288 447 | 1 192 798 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 473 890 | 617 130 | 707 186 | 662 195 | 605 977 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | 473 890 | 617 130 | 707 186 | 662 195 | 605 977 |
| Net financials | −34 | 79 | 3 845 | 38 699 | 29 746 |
| Profit before tax | 473 856 | 617 209 | 711 030 | 700 894 | 635 722 |
| Tax | −101 500 | −126 006 | −145 841 | −145 099 | −131 147 |
| Net profit | 372 356 | 491 203 | 565 189 | 555 795 | 504 575 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 606 140 | 577 076 | 917 612 | 1 436 153 | 791 412 |
| Equity | 537 088 | 503 607 | 773 679 | 1 329 474 | 733 999 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 67 363 | 67 453 | 133 124 | 95 888 | 46 471 |
| Total debt | 67 363 | 67 453 | 133 124 | 95 888 | 46 471 |
EBITDA margin
50.8%
This company
15.8%
Market median
+222% vs market
20202024
Equity ratio
92.7%
This company
38.2%
Market median
+143% vs market
20202024
Return on equity
68.7%
This company
18.4%
Market median
+273% vs market
20202024
Net profit margin
42.3%
This company
8.1%
Market median
+422% vs market
20202024
Asset turnover
1.51×
This company
1.12×
Market median
+35% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MP Chief Auditor | Chief Auditor | 2020 |
| Former (2) | ||
FG External Signatory | External Signatory | 2020 – 2022 |
LM Chief Auditor | Chief Auditor | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MERCK CHEMICALS B.V.
Merck Life Science AB (this company)Board members of Merck Life Science AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Pernilla Rehnberg | Chief Auditor | 0 companies |
| Fredrik Gullbring | External Signatory | 0 companies |
| Lars Mikael Käll | Chief Auditor | 0 companies |
| Renée Christine Tunold | Board of Directors | 0 companies |
| Tiina Marjatta Puhakka | Board of Directors | 0 companies |
| Johan Anders Wesslau | Chairman | 0 companies |
| Signe Lovisa Fridström | Board of Directors | 0 companies |
| Ulf Karl Axel Uby | Board of Directors | 0 companies |